$260 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | $9,550,000 | +8.1% | 370,000 | 0.0% | 3.67% | +6.4% | |
| STML | Stemline Therapeutics Inc | $7,862,000 | +4.6% | 492,930 | 0.0% | 3.02% | +3.0% | |
| IONS | Ionis Pharmaceuticals Inc | $5,271,000 | -5.5% | 126,500 | 0.0% | 2.02% | -6.9% | |
| TRXC | Transenterix Inc | $3,823,000 | +154.4% | 889,082 | 0.0% | 1.47% | +150.5% | |
| ALNY | Alnylam Pharmaceuticals Inc | $3,624,000 | -17.3% | 36,800 | 0.0% | 1.39% | -18.6% | |
| SRPT | Sarepta Therapeutics Inc | $3,568,000 | +78.4% | 27,000 | 0.0% | 1.37% | +75.6% | |
| BLUE | Bluebird Bio Inc | $3,137,000 | -8.1% | 20,000 | 0.0% | 1.20% | -9.5% | |
| AGIO | Agios Pharmaceuticals Inc | $3,074,000 | +3.0% | 36,500 | 0.0% | 1.18% | +1.4% | |
| DCPH | Deciphera Pharmaceuticals Inc | $3,028,000 | +96.4% | 77,000 | 0.0% | 1.16% | +93.2% | |
| SGEN | Seattle Genetics Inc | $2,821,000 | +26.9% | 42,500 | 0.0% | 1.08% | +24.9% | |
| KALV | Kalvista Pharmaceuticals Inc | $2,612,000 | -13.2% | 322,436 | 0.0% | 1.00% | -14.5% | |
| FGEN | FibroGen Inc | $1,963,000 | +35.5% | 31,400 | 0.0% | 0.75% | +33.5% | |
| CBAY | Cymabay Therapeutics Inc | $1,945,000 | +3.2% | 145,000 | 0.0% | 0.75% | +1.6% | |
| MRUS | Merus N V | $1,692,000 | +21.6% | 75,060 | 0.0% | 0.65% | +19.7% | |
| GMED | Globus Med Inc | $1,463,000 | +1.2% | 29,000 | 0.0% | 0.56% | -0.4% | |
| GWPH | GW Pharmaceuticals Plcads | $1,339,000 | +23.8% | 9,600 | 0.0% | 0.51% | +21.8% | |
| SUPN | Supernus Pharmaceuticals Inc | $1,253,000 | +30.7% | 20,953 | 0.0% | 0.48% | +28.6% | |
| HZNP | Horizon Pharma Plc | $1,142,000 | +16.6% | 69,000 | 0.0% | 0.44% | +14.9% | |
| PRTK | Paratek Pharmaceuticals Inc | $1,051,000 | -21.9% | 103,500 | 0.0% | 0.40% | -23.0% | |
| RIGL | Rigel Pharmaceuticals Inc | $1,043,000 | -19.9% | 370,000 | 0.0% | 0.40% | -21.3% | |
| AERI | Aerie Pharmaceuticals Inc | $998,000 | +24.4% | 14,779 | 0.0% | 0.38% | +22.4% | |
| ONCE | Spark Therapeutics Inc | $992,000 | +24.2% | 12,000 | 0.0% | 0.38% | +22.1% | |
| FOLD | Amicus Therapeutics Inc | $915,000 | +3.9% | 58,600 | 0.0% | 0.35% | +2.0% | |
| PTLA | Portola Pharmaceuticals Inc | $906,000 | +15.6% | 24,000 | 0.0% | 0.35% | +13.7% | |
| SBPH | Spring Bk Pharmaceuticals Inc | $860,000 | -21.2% | 73,000 | 0.0% | 0.33% | -22.5% | |
| VKTX | Viking Therapeutics Inc | $664,000 | +117.7% | 70,000 | 0.0% | 0.26% | +114.3% | |
| RDUS | Radius Health Inc | $554,000 | -17.9% | 18,799 | 0.0% | 0.21% | -19.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.